BioMarin Pharmaceutical Inc. (BMRN) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

BioMarin Pharmaceutical shareholders at a glance

The largest holder of BioMarin Pharmaceutical stock is BlackRock Advisors LLC, with 18.7 million shares (9.68% of the company), worth about $1.22 billion as of September 25, 2026. The 10 largest holders together own 51.9%.

In Q2 2026, 592 institutional holdings reports listed shares worth $12.30 billion.

Insiders reported 51 transactions in the last two years: 10 sales worth $4.31 million and no purchases. The newest one on file is from May 7, 2026 (Friberg Gregory R, Officer).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 7, 2026.

BMRN logo

BioMarin Pharmaceutical Inc.

BMRNUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
592
Options Value
$138.00M
Value (excl. Options)
$12.30B
Shares (excl. Options)
-

Ownership by Type

Geographic Distribution

Largest BioMarin Pharmaceutical shareholders

HolderShares% of companyValue
BlackRock Advisors LLC18.7 million9.68%$1.2B
Dodge & Cox14.8 million7.67%$968.0M
PRIMECAP Management Co.14.2 million7.33%$926.0M
Vanguard Capital Management LLC8.7 million4.52%$570.0M
Vanguard Portfolio Management LLC8.6 million4.47%$564.0M
Norges Bank (13F)8.2 million4.24%$535.0M
State Street Corporation7.8 million4.03%$509.0M
Viking Global Investors LP7.6 million3.94%$497.0M
Vestal Point Capital LP6.0 million3.11%$393.0M
AQR Capital Management LLC5.7 million2.94%$372.0M

As of September 25, 2026.

BioMarin Pharmaceutical institutional holdings by quarter

QuarterReportsSharesValue
Q2 2026592–$12.3B
Q1 2026586184.0 million$10.4B
Q4 2025580189.0 million$11.2B
Q3 2025618180.0 million$9.8B
Q2 2025630186.0 million$10.2B
Q1 2025628187.0 million$13.1B
Q4 2024596184.0 million$12.1B
Q3 2024614184.0 million$12.9B

Shares and value held by institutions that file quarterly holdings reports (options not included).

BioMarin Pharmaceutical insider trades

InsiderDateTitleTransactionValue
Friberg Gregory RMay 7, 2026OfficerSale at price 53.85 per share.$176,682
Davis George EricMar 16, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Guyer Charles GregMar 16, 2026Chief Technology OfficerStock Award(Grant) at price 0.00 per share.–
Hardy AlexanderMar 16, 2026Chief Executive OfficerStock Award(Grant) at price 0.00 per share.–
Hubbard CristinMar 16, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Friberg Gregory RMar 16, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Mueller Brian RMar 16, 2026Chief Financial OfficerStock Award(Grant) at price 0.00 per share.–
Guyer Charles GregMar 11, 2026Chief Technology OfficerSale at price 60.46 per share.$996,744
Davis George EricFeb 26, 2026OfficerSale at price 61.36 per share.$1.6M
Friberg Gregory RFeb 26, 2026OfficerSale at price 60.38 per share.$381,937
Davis George EricFeb 25, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Guyer Charles GregFeb 25, 2026Chief Technology OfficerStock Award(Grant) at price 0.00 per share.–

Newest 12 of 51 insider transactions in the last two years.

Questions and answers

Who owns the most BioMarin Pharmaceutical stock?

BlackRock Advisors LLC, with 9.68% of the company (as of September 25, 2026). Next: Dodge & Cox (7.67%) and PRIMECAP Management Co. (7.33%).

How many institutions own BioMarin Pharmaceutical stock?

592 institutional holdings reports listed BioMarin Pharmaceutical shares in Q2 2026 worth $12.30 billion.

Are BioMarin Pharmaceutical insiders buying or selling the stock?

In the last two years insiders reported 10 sales and no purchases (51 transactions in all); the newest on file is from May 7, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube